Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:36 AM ET 8-K
Executive Compensation Duke Robotics Corp. DUKR

Duke Robotics Executive Compensation

Duke Robotics Corp. appointed Avi Levin as Chief Financial Officer, effective October 1, 2026, succeeding Shlomo Zakai. Mr. Levin's compensation package includes a monthly base salary of approximately $17,227, an annual performance bonus of up to eight monthly salaries, and the future grant of 35,000 stock options vesting over three years.

Counterparty
Avi Levin
8:34 AM ET 8-K
Investor Presentation Envista Holdings Corp NVST

Envista Holdings Investor Presentation

Envista Holdings Corporation is hosting its 2026 Investor Day on September 17, 2026. During the event, executive leadership will present the company's long-term strategy, innovation priorities, and financial objectives to analysts and investors.

8:31 AM ET Form 4
Insider Buying Star Bulk Carriers Corp. SBLK

Star Bulk Carriers COO Nikolaos Reskos Buys $283K of Stock

Nikolaos Reskos, COO, bought 10,000 shares of Star Bulk Carriers Corp. at $28.27 a share, worth $283K in total on Sep 15, 2026. Shares held after the trade: 410,875 (+2.5%).

Value
$283K
Shares
10,000
Price
$28.27
Role
COO
Holding change
+2.5%
Trade date
Sep 15, 2026
8:31 AM ET 8-K
Clinical Trial Data Telomir Pharmaceuticals, Inc. TELO

Telomir Pharmaceuticals Clinical Trial Data

Telomir Pharmaceuticals announced the publication of peer-reviewed preclinical data in the International Journal of Molecular Sciences demonstrating that Telomir-Zn restored visual function and retinal structure in a model of age-related macular degeneration (AMD). The study showed that 14 days of oral treatment significantly improved visual performance, reduced mitochondrial oxidative stress, and increased telomeric DNA content. While the company remains focused on its Phase 1/2 clinical trial for triple-negative breast cancer, these findings suggest the drug's metal-dependent epigenetic biology may have broader applications beyond oncology.

8:31 AM ET 8-K
Other 8-K Filing bioAffinity Technologies, Inc. BIAF

bioAffinity Technologies Other 8-K Filing

bioAffinity Technologies announced that the Hong Kong Intellectual Property Department has granted a patent (HK40048460) for its CyPath Lung diagnostic technology. This patent, alongside a previously granted Chinese patent, strengthens the company's intellectual property position in the Asian market, which accounts for nearly two-thirds of global lung cancer cases.

Counterparty
Hong Kong Intellectual Property Department
8:31 AM ET 8-K
Business Update Mira Pharmaceuticals, Inc. MIRA

Mira Pharmaceuticals Business Update

MIRA Pharmaceuticals has advanced its Ketamir-2 Phase 2a clinical program for chemotherapy-induced peripheral neuropathy (CIPN) toward site initiation following a protocol review by the FDA. The company has incorporated the regulator's feedback and submitted the protocol for Institutional Review Board (IRB) review, with site initiation targeted for the first quarter of 2027.

Counterparty
FDA
8:30 AM ET 8-K
M&A Deal Colony Bankcorp Inc CBAN

Colony Bankcorp Signs $163M M&A Deal with First Reliance Bancshares, Inc.

Colony Bankcorp announced it has received all required regulatory approvals for its previously announced $163 million acquisition of First Reliance Bancshares. The merger, which will create a combined institution with approximately $5 billion in assets, is expected to close on November 1, 2026, pending shareholder approvals.

Value
$163M
Counterparty
First Reliance Bancshares, Inc.
8:16 AM ET 8-K
Loan & Debt Clarivate PLC CLVT

Clarivate $75M Debt Financing with Clarivate Science Holdings Corporation

Clarivate Plc's subsidiary, Clarivate Science Holdings Corporation, has commenced a cash tender offer to repurchase up to $75 million in aggregate principal amount of its 3.875% Senior Secured Notes due 2028. The offer is part of a debt management strategy with the total consideration to be determined based on a fixed spread over a reference U.S. Treasury security yield.

Value
$75M
Counterparty
Clarivate Science Holdings Corporation
8:14 AM ET 8-K
M&A Deal Littelfuse Inc LFUS

Littelfuse M&A Deal with Elmos Semiconductor SE

Littelfuse entered into an amended share purchase and supply agreement with Elmos Semiconductor SE regarding its previously acquired 200mm wafer fab in Dortmund, Germany. The amendment simplifies legacy contractual arrangements and increases strategic flexibility for the asset in exchange for a one-time fee of €24.6 million. This update follows the original acquisition and capacity-sharing arrangement announced in 2023 and 2024.

Counterparty
Elmos Semiconductor SE
Term
through 2029
8:12 AM ET 8-K
Loan & Debt HyOrc Corp HYOR

HyOrc Debt Financing Update with GS Capital Partners, LLC

HyOrc Corporation entered into an amendment with GS Capital Partners to extend the maturity date of a $150,000 promissory note from September 2026 to March 2027. In exchange for the extension, the principal balance was increased to $165,000, and 250,000 previously returnable shares held by the lender will now be retained permanently by GS Capital.

Counterparty
GS Capital Partners, LLC
Term
through March 13, 2027
8:10 AM ET 8-K
Leadership Change World Kinect Corp WKC

World Kinect Leadership Change

World Kinect Corporation announced that co-founder Michael J. Kasbar will step down as Executive Chairman effective December 31, 2026. The Board has appointed independent director Ken Bakshi to succeed him as Chairman of the Board on the same date. Mr. Kasbar will remain a member of the Board and will receive severance benefits as per his previous employment agreement.

8:07 AM ET 8-K
Shareholder Meeting Freedom Holding Corp. FRHC

Freedom Holding Shareholder Meeting

Freedom Holding Corp. held its 2026 Annual Meeting of Stockholders on September 16, 2026. Shareholders elected Askar Tashtitov and Boris Cherdabayev as Class I directors, approved executive compensation on an advisory basis, and ratified Deloitte LLP as the independent accounting firm for fiscal year 2027.

8:05 AM ET 8-K
Loan & Debt Hallador Energy Co HNRG

Hallador Energy $675M Debt Financing with Kennedy Lewis Investment Management LLC

Hallador Energy entered into a $600 million senior secured term loan facility with Kennedy Lewis Investment Management and established the ability to add a $75 million super-priority revolving credit facility. The proceeds will primarily fund the development and construction of the company's 460-megawatt Turtle Creek Gas project, as well as the repayment of $120 million in existing debt.

Value
$675M
Counterparty
Kennedy Lewis Investment Management LLC
Term
3 years
8:04 AM ET 8-K
M&A Deal Aethlon Medical Inc AEMD

Aethlon Medical Signs $150M M&A Deal with North Immunology, Inc.

Aethlon Medical (AEMD) has entered into a definitive agreement to acquire North Immunology in an all-stock merger transaction valued at a framework of $150 million for the target. Concurrent with the merger, North Immunology secured an oversubscribed $180 million private placement from a syndicate of healthcare investors to fund operations into 2028. The combined company will focus on advancing NOR-101, a bispecific antibody for atopic dermatitis, and will trade under the new ticker NRTX.

Value
$150M
Counterparty
North Immunology, Inc.
8:01 AM ET 8-K
M&A Deal HeartSciences Inc. HSCS

HeartSciences M&A Deal with Fortitude Mining Holdings, Inc.

HeartSciences provided a status update on its pending merger with Fortitude Mining Holdings, Inc., announcing that Jaime Leverton has been appointed CEO of Fortitude and is expected to lead the combined company (to be renamed Fortitude Mining Group, Inc.) upon closing. The update follows the definitive merger agreement signed on June 23, 2026, as the vertically-integrated Zcash mining platform prepares for its public listing on Nasdaq under the ticker 'TUDE'.

Counterparty
Fortitude Mining Holdings, Inc.
8:01 AM ET 8-K
Investor Presentation FB Financial Corp FBK

FB Financial Investor Presentation

FB Financial Corporation filed a formal investor presentation dated September 17, 2026, to be used by management in meetings with investors and analysts. The presentation focuses on fixed income and provides updates on the company's strategic plans and expectations regarding economic markets.

8:01 AM ET 8-K
Other 8-K Filing StableCoinX Inc. USDE

StableCoinX Other 8-K Filing

StablecoinX entered into a waiver agreement with the Ethena Foundation to permanently release lock-up and vesting restrictions on ENA tokens held by the company, effective October 5, 2026. The agreement also establishes a framework for the company to sell these tokens to fund working capital and strategic requirements, subject to a right of first refusal by the Foundation.

Counterparty
Ethena Foundation
8:00 AM ET 8-K
Stock Buyback Dominari Holdings Inc. DOMH

Dominari Holdings Announces $5M Stock Buyback

Dominari Holdings Inc. announced that its board of directors has authorized a share repurchase program to buy back up to $5 million of its outstanding common stock. The repurchases will be conducted through open market transactions under Rule 10b5-1 and Rule 10b-18, reflecting management's commitment to shareholder value and a strong year-end balance sheet.

Value
$5M
7:50 AM ET 8-K
Investor Presentation Brinker International, Inc EAT

Brinker International Investor Presentation

Brinker International is hosting an Investor Day to outline its long-term growth strategy and financial targets through fiscal 2029. The company expects 4% to 6% annual revenue growth and double-digit annual growth in net income per diluted share, supported by plans to open 30 new restaurants annually by 2029.

Term
through fiscal 2029
7:37 AM ET 8-K
Business Update Allstate Corp ALL

Allstate Business Update

Allstate announced estimated catastrophe losses for August 2026 of $748 million ($591 million after-tax), primarily driven by 21 events including a significant wind and hail event. Total catastrophe losses for the first two months of the third quarter (July and August) reached $1.43 billion.

Term
August 2026
7:36 AM ET 8-K
Loan & Debt Cleanspark, Inc. CLSK

Cleanspark $2.23B Debt Financing

CleanSpark's subsidiary, CSDC Finance I, LLC, announced a private offering of $2.227 billion in senior secured notes due 2031. The debt financing is intended to support the development of the Sandersville data center campus, a 175 MW AI-focused facility leased to a global technology company.

Value
$2.23B
Term
2031
7:33 AM ET Form 4
Insider Selling DHT Holdings, Inc. DHT

DHT Holdings Insider Erik Lind Sells $674K of Stock

Erik Lind sold 30,000 shares of DHT Holdings, Inc. at $22.46 a share, worth $674K in total on Sep 15, 2026. Shares held after the trade: 132,294 (-18.5%).

Value
$674K
Shares
30,000
Price
$22.46
Holding change
-18.5%
Trade date
Sep 15, 2026
7:31 AM ET 8-K
Divestiture Atlanticus Holdings Corp ATLC

Atlanticus Holdings Divestiture for $71.2M

Atlanticus Holdings Corporation completed the sale of its CAR Auto Finance operations to an unaffiliated third party for approximately $71.2 million. The consideration consists of $56.2 million in cash and a $15.0 million seller note, and the transaction results in the company exiting its Auto Finance segment to focus on higher-growth consumer credit products.

Value
$71.2M
7:31 AM ET Form 4
Insider Buying Quantum X Labs Inc. QXL

Quantum X Labs Co-CEO Yakov Baranes Buys $24.4K of Stock

Yakov Baranes, Co-CEO, bought 5,000 shares of Quantum X Labs Inc. at $4.88 a share, worth $24.4K in total on Sep 15, 2026. Shares held after the trade: 358,177 (+1.4%).

Value
$24.4K
Shares
5,000
Price
$4.88
Role
Co-CEO
Holding change
+1.4%
Trade date
Sep 15, 2026
7:31 AM ET 8-K
M&A Deal Bank7 Corp. BSVN

Bank7 Signs $108M M&A Deal with Century Financial Services Corporation

Bank7 Corp. entered into a definitive agreement to acquire Century Financial Services Corporation, the parent company of Santa Fe-based Century Bank, for approximately $108.1 million in combined cash and stock. The deal expands Bank7's footprint into the New Mexico market and will create a combined institution with approximately $3.3 billion in total assets. Century shareholders will receive $70 million in cash and 1,232,657 shares of Bank7 common stock.

Value
$108M
Counterparty
Century Financial Services Corporation

“This transaction extends our footprint into an attractive and neighboring Southwest market, represents a disciplined use of our excess capital, and positions the combined organization to deliver personalized, high-touch service to even more business owners and entrepreneurs — all to the benefit of our customers, communities, and shareholders.”

Thomas L. Travis, President and CEO of Bank7

“We believe this is a great opportunity for both banks to enhance their presence in the southwest and create a stronger more robust banking institution to benefit our customers, employees, and communities.”

Max Myers, CEO of Century Bank
7:26 AM ET 8-K
Leadership Change Old Dominion Electric Cooperative

Old Dominion Electric Cooperative Leadership Change

Old Dominion Electric Cooperative elected Keith M. Dunn to its board of directors, effective September 15, 2026. Mr. Dunn replaces Paul H. Brown on the board and was recommended by Prince George Electric Cooperative.

Counterparty
Keith M. Dunn
7:24 AM ET Form 4
Insider Selling Amer Sports, Inc. AS

Amer Sports Chief Strategy Officer Wen-Chang (Victor) Chen Sells $3.12M of Stock

Wen-Chang (Victor) Chen, Chief Strategy Officer, sold 117,461 shares of Amer Sports, Inc. at $26.60 a share, worth $3.12M in total on Sep 15, 2026. Shares held after the trade: 434,855 (-21.3%).

Value
$3.12M
Shares
117,461
Price
$26.60
Role
Chief Strategy Officer
Holding change
-21.3%
Trade date
Sep 15, 2026
7:18 AM ET 8-K
Dividend Indivior Pharmaceuticals, Inc. SUPN

Indivior Pharmaceuticals Dividend

Indivior Pharmaceuticals declared a special cash dividend of $8.13 per share to be paid to stockholders of record as of October 30, 2026. The payment is strictly contingent upon the closing of Indivior's pending merger with Supernus Pharmaceuticals, which is expected to occur on or about November 2, 2026. Supernus stockholders will not receive this dividend for shares received as merger consideration.

Counterparty
Supernus Pharmaceuticals, Inc.
7:17 AM ET 8-K
Dividend Aecom ACM

Aecom Dividend

AECOM's Board of Directors has declared a quarterly cash dividend of $0.31 per share. The dividend is payable on October 30, 2026, to stockholders of record as of October 14, 2026, as part of the company's ongoing quarterly dividend program.

7:14 AM ET 8-K
Loan & Debt CoreWeave, Inc. CRWV

CoreWeave $3.5B Debt Financing

CoreWeave announced a private offering of $3.0 billion in convertible senior notes due 2033, with an additional $500 million option for initial purchasers. The company intends to use the proceeds to fund capped call transactions to mitigate potential dilution and for general corporate purposes.

Value
$3.5B
Term
through April 2033

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.